Code of Federal Regulations · Subpart

Subpart B — Labeling Requirements For Prescription Drugs And/or Insulin

21 C.F.R. pt. 201, subpt. B

• § 201.50 Statement Of Identity
• § 201.51 Declaration Of Net Quantity Of Contents
• § 201.55 Statement Of Dosage
• § 201.56 Requirements On Content And Format Of Labeling For Human Prescription Drug And Biological Products
• § 201.57 Specific Requirements On Content And Format Of Labeling For Human Prescription Drug And Biological Products Described In § 201.56(b)(1)
• § 201.58 Waiver Of Labeling Requirements